Spinal Muscular Atrophy Type 3
Symptoms, Doctors, Treatments, Advances & More

Spinal Muscular Atrophy Type 3 Overview

Save information for later
Sign Up

Learn About Spinal Muscular Atrophy Type 3

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Spinal Muscular Atrophy Type 3 Local Doctors?
Distinguished in Spinal Muscular Atrophy Type 3
Neuromusculoskeletal Medicine | Neurology
Distinguished in Spinal Muscular Atrophy Type 3
Neuromusculoskeletal Medicine | Neurology

Swedish Neurology - Cherry Hill

550 17th Avenue, Suite 400, 
Seattle, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

"Dr. Elliott serves as Chief of Neurology for the Swedish Neuroscience Institute; Medical Director, Neuromuscular Medicine and Medical Director, ALS Clinic. He is also board-certified in Electrodiagnostic Medicine. Dr. Elliott was selected by both Seattle Magazine and Seattle Metropolitan Magazine as a Top Doctor. ""It is a privilege to practice neurology and I am honored by those who entrust their care with me. I believe that listening is the foundation upon which excellent care is built.""". Dr. Elliott is rated as a Distinguished provider by MediFind in the treatment of Spinal Muscular Atrophy Type 3. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3. Dr. Elliott is board certified in American Board Of Psychiatry And Neurology and American Board Of Electrodiagnostic Medicine. Dr. Elliott is currently accepting new patients.

Distinguished in Spinal Muscular Atrophy Type 3
Distinguished in Spinal Muscular Atrophy Type 3

Vanderbilt Medical Group- Teleneurology

1161 21st Ave South, A-0118 Medical Center North, 
Nashville, TN 
Languages Spoken:
English
Offers Telehealth

Christopher Lee is a Neurologist practicing medicine in Nashville, Tennessee. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Spinal Muscular Atrophy Type 3. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Guillain-Barre Syndrome, and Gamma Knife Radiosurgery. Dr. Lee is board certified in American Board Of Psychiatry & Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Spinal Muscular Atrophy Type 3
Elite in Spinal Muscular Atrophy Type 3

Clinical Research Center

4350 Shawnee Mission Parkway, 
Fairway, KS 
Experience:
21+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Jeffrey Statland is a Neurologist practicing medicine in Fairway, Kansas. He has been practicing medicine for over 21 years. Dr. Statland is rated as an Elite provider by MediFind in the treatment of Spinal Muscular Atrophy Type 3. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Paramyotonia Congenita, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Gastrostomy. Dr. Statland is board certified in American Board Of Psychiatry And Neurology, Neurology - 2011. Dr. Statland is currently accepting new patients.

What are the latest Spinal Muscular Atrophy Type 3 Clinical Trials?
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Summary: The purpose of this research is (1) to identify disease specific walking-related digital biomarkers of disease severity, and (2) monitor longitudinal changes in natural environments, for extended periods of time, in DMD and SMA.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA)

Summary: This double-blind, Phase 2, multiple-dose study will be conducted to evaluate the PK/PD, efficacy, safety, and tolerability of apitegromab in subjects \<2 years old with 5q autosomal recessive SMA who have delayed motor milestones for their age attributed to SMA at the discretion of the Investigator or a Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP-INTEND) score...